29 related articles for article (PubMed ID: 7551239)
21. Review of L-tyrosine confirming its safe human use as an adjuvant.
Baldrick P; Richardson D; Wheeler AW
J Appl Toxicol; 2002; 22(5):333-44. PubMed ID: 12355563
[TBL] [Abstract][Full Text] [Related]
22. Influenza A (H5N1) pandemic prototype vaccine Fluval.
Vajo Z
Expert Rev Vaccines; 2009 May; 8(5):619-24. PubMed ID: 19397418
[TBL] [Abstract][Full Text] [Related]
23. (How) do aluminium adjuvants work?
Brewer JM
Immunol Lett; 2006 Jan; 102(1):10-5. PubMed ID: 16188325
[TBL] [Abstract][Full Text] [Related]
24. Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine.
Nøkleby H
Expert Rev Vaccines; 2007 Oct; 6(5):863-9. PubMed ID: 17931164
[TBL] [Abstract][Full Text] [Related]
25. Stearyl tyrosine. An organic equivalent of aluminum-based immunoadjuvants.
Penney C
Pharm Biotechnol; 1995; 6():611-24. PubMed ID: 7551239
[No Abstract] [Full Text] [Related]
26. Aluminium adjuvants--in retrospect and prospect.
Lindblad EB
Vaccine; 2004 Sep; 22(27-28):3658-68. PubMed ID: 15315845
[TBL] [Abstract][Full Text] [Related]
27. [Adjuvants for human vaccines].
Bröker M; Beyer C
Pharm Unserer Zeit; 2008; 37(1):42-51. PubMed ID: 18081081
[No Abstract] [Full Text] [Related]
28. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
Hem SL; Hogenesch H
Expert Rev Vaccines; 2007 Oct; 6(5):685-98. PubMed ID: 17931150
[TBL] [Abstract][Full Text] [Related]
29. An aluminium adjuvant in a vaccine is an acute exposure to aluminium.
Exley C
J Trace Elem Med Biol; 2020 Jan; 57():57-59. PubMed ID: 31561170
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
